Do you want to read an article? Please log in or register.
Susceptibility-Guided Versus Empirical First-Line Therapy of Helicobacter pylori Infection in Adults: A Systematic Review and Meta-Analysis
Helicobacter Pylori
Related content
Helicobacter Pylori
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
Helicobacter
Parra P, Nyssen OP, Gisbert JP
doi: 10.1111/hel.70099
Helicobacter Pylori
Effects of Helicobacter pylori Eradication on the Risk and Clinical Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
Helicobacter
Li X, Tao Y, Li H, Mai L, He X, Yan J, Yang X
doi: 10.1111/hel.70092
Helicobacter Pylori
Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial
Helicobacter
Hsu PI, Sheu MJ, Chen CL, Lei WY, Shih CA, Tsay FW, Kao SS, Shie CB, Wu PJ, Kuo CH, Yang JC, Chen KY, Chuah SK, Lee CL, Lee HC, Tai WC, Tsai TJ, Kao JY, Wu DC, Taiwan Acid‐related Disease & Microbiota (TARD‐M) Consortium
doi: 10.1111/hel.70131
RECOMMENDED
Inflammatory Bowel Disease
Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Sul HH, Gewehr DM, Kang H, Junior OR, Ungaro RC, Bernstein CN
doi: 10.1093/ecco-jcc/jjaf202
Inflammatory Bowel Disease
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis
Adv Ther
Schreiber S, Danese S, Colombel JF, Hisamatsu T, Irving PM, Park H, Kim DH, Lee YN, Hanauer SB
doi: 10.1007/s12325-025-03447-6
Further Publications
Efficacy and Safety of Obeticholic Acid as Second-Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis
J Gastroenterol Hepatol
Abreu ES, Fernandes GP, Lacerda HC, Reginato PH, Ferreira Neves HA, Sanchez Gonzalez CD, Eaton JE, Cançado GGL
doi: 10.1111/jgh.70094
Helicobacter Pylori
Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial
Helicobacter
Zhu YC, Li K, Sun A, Lin S, Zhang J, Meng S, Xia X, Gao H, Lin J, Jiang W
doi: 10.1111/hel.70147
Hepatology
Global epidemiology of bacterial infections in patients with cirrhosis: a systematic review and meta-analysis
J Hepatol
Cai J, Yip TC, Wong GL, Zhang Y, Chan PP, Liu X, Zhang T, Fong AT, Chi Z, Lai KM, Lau KC, Ching SL, Garcia-Tsao G, Abraldes JG, Lui GC, Wong VW, Sun J, Lai JC
doi: 10.1016/j.jhep.2026.02.007
Helicobacter Pylori
Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial
Helicobacter
El-Azab G, Abdel Salam S, Moustafa E, Abuoelhassan A, Shamseya A, Ellakany A, Abdelaal U, Assem M, Khalil F, Mahmoud A, Elsabaawy M, Hussein B, Ezz-Eldin M, Hassany S, Zaghloul N, Magdy M
doi: 10.1111/hel.70104